Biosystems International
Debrecen
About Biosystems International
BioSystems International (BSI) brings biomarkers to the bedside. They improve pharmaceutical drug discovery and development productivity, i.e. safer and more effective drugs at lower costs and in less time. BSI delivers tools for disease management.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Funding stage: M&A
- Last round: Series D (Oct 2020)
- Website: biosys-intl.com
- Phone: +33 164982000
Industries & Categories
Biotechnology, Developer Platform, Health Care
Social Profiles
Canonical: https://fsome.com/organization/biosystems-international-127895 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.